In conclusion, a combination of ADC values and TA based on three MRI sequences was developed to provide a noninvasive method for preoperatively predicting the expression levels of Ki-67 and p53 in EC. To some extent, this noninvasive imaging marker can compensate for the limitation of endometrium curettage biopsy and adverse impact of tumor heterogeneity, and it provide an objective imaging basis for clinical and accurate individualized treatment.
This abstract and the presentation materials are available to members only; a login is required.